Lidia Avalle

1.6k citations
25 papers · 1.1k indexed · h-index 17
Topics
Cytokine Signaling Pathways and Interactions (10 papers)Protein Tyrosine Phosphatases (3 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)

In The Last Decade

Lidia Avalle

23 papers receiving 1.1k citations

Peers

Lidia Avalle
Comparison fields: 5 of 89
  • Molecular Biology 519
  • Oncology 491
  • Immunology 413
  • Cancer Research 217
  • Pathology and Forensic Medicine 111
Replace Nitin Chakravarti with:
Nitin Chakravarti United States
Jennifer Yeh United States
Samita Bhattacharya United States
Anne Quillet‐Mary France
Hasita Horlad Japan
Divya Chaudhary United States
Steve Enkemann United States
Nameer B. Kirma United States
Gill Webster New Zealand
Liquan Xue United States
Lidia Avalle relative to Nitin Chakravarti United States Nitin Chakravarti's profile →
Citations per field
00.5×
Nitin Chakravarti · 1×
Citations per year

Countries citing papers authored by Lidia Avalle

Since Specialization
Citations

This map shows the geographic impact of Lidia Avalle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Avalle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Avalle more than expected).

Fields of papers citing papers by Lidia Avalle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Avalle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Avalle. The network helps show where Lidia Avalle may publish in the future.

Co-authorship network of co-authors of Lidia Avalle

This figure shows the co-authorship network connecting the top 25 collaborators of Lidia Avalle. A scholar is included among the top collaborators of Lidia Avalle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidia Avalle. Lidia Avalle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 0
4 4
5 5
6 50
7 27
8 62
9 16
10 22
11 45
12 24
13 10
14 26
15 76
16 94
17 125
18 24
19 1
20 211

About Lidia Avalle

Lidia Avalle is a scholar working on Oncology, Immunology and Cancer Research, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (10 papers), Protein Tyrosine Phosphatases (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Immunology (413 citations), Oncology (491 citations) and Cancer Research (217 citations). Lidia Avalle has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Valeria Poli, Enzo Calautti, Gabriella Regis, Sara Pensa, Francesco Novelli, Annalisa Camporeale, Andrea Camperi, Laura Seclì, Mara Brancaccio and Federica Fusella. Their work appears in journals such as Nature Communications, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026